Literature DB >> 14751140

Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix.

Kuniko Utsugi1, Yoshio Shimizu, Futoshi Akiyama, Satoshi Umezawa, Katsuhiko Hasumi.   

Abstract

OBJECTIVES: The objectives of this study are to analyze the clinicopathologic features of villoglandular papillary adenocarcinoma (VGPA) of the uterine cervix and to discuss the management thereof. We examined 13 patients with VGPA.
METHODS: Clinical profiles, including patient age, clinical stage, surgical procedure, and outcome, were recorded. Pathologically, macroscopic features, polypoid tumor size, horizontal spread and depth of endophytic tumor, nuclear atypicality, mitotic count, lymph capillary space invasion, and lymph node metastasis were investigated.
RESULTS: The median age of 13 patients was 45 years, with 10 and 3 patients staged Ib and IIb, respectively. All the patients underwent hysterectomy and pelvic lymphadenectomy and are alive without recurrence. Macroscopically, the tumor showed a polypoid pattern in 8 patients and a flat pattern in the remaining 5 patients. Polypoid tumor size ranged between 4 x 2 and 20 x 15 mm. Horizontal spread and depth of endophytic tumor ranged between 8 and 30 mm and between 3 and 11 mm, respectively. The tumor in all the 13 patients except 1 showed moderate nuclear atypicality. The mean mitotic count was 43/10 high-power fields. Lymph capillary space invasion was present in 4 patients, 1 of whom also had bulky lymph node metastases.
CONCLUSIONS: VGPA has been reported to rarely involve lymph capillary space invasion or lymph node metastasis, leading some surgeons to conduct less radical surgeries such as conization. Nevertheless, we encountered patients with these pathologic risk factors. Much caution should be exercised in managing patients with VGPA.

Entities:  

Mesh:

Year:  2004        PMID: 14751140     DOI: 10.1016/j.ygyno.2003.10.020

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix with a focal high-grade component: is there a need for reassessment?

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

2.  Villoglandular papillary adenocarcinoma of the uterine cervix: A report of 4 cases and a review of the literature.

Authors:  Qiang-Yong Zhou; Hai-Yan Chen; Si-Meng Yang; Yue-Hua Li; Xue-Qing Wu
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

3.  A Case of Villoglandular Papillary Adenocarcinoma of the Uterine Cervix Diagnosed during Early Pregnancy Followed by Successful Term Delivery.

Authors:  Noriyuki Takai; Chihiro Hayashita; Satoru Nakamura; Hisashi Narahara; Hideo Matsumoto
Journal:  Case Rep Med       Date:  2010-06-10

4.  Two cases of endocervical villoglandular adenocarcinoma: Support for conservative management.

Authors:  Sarah Dilley; Colin Newbill; Tanja Pejovic; Elizabeth Munro
Journal:  Gynecol Oncol Rep       Date:  2015-02-27

5.  Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome.

Authors:  Peng Guo; Pengfei Liu; Junjun Yang; Tong Ren; Yang Xiang
Journal:  Cancer Manag Res       Date:  2018-09-26       Impact factor: 3.989

Review 6.  Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.

Authors:  Anna K Dietl; Matthias W Beckmann; Konrad Aumann
Journal:  Arch Gynecol Obstet       Date:  2021-05-25       Impact factor: 2.344

7.  Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?

Authors:  U Chul Ju; Woo Dae Kang; Seok Mo Kim
Journal:  J Gynecol Oncol       Date:  2018-03-20       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.